Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial Patients with pretreated R/M CC were randomly assigned to receive camrelizumab (200 mg intravenously once ...

The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this ...

Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...

Patient-reported outcomes (PROs) are widely used in oncology clinical trials to capture patients’ own perspectives on ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid tumors. Several oncology companies announced key trial milestones this week ...

Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings. The clinical ...

Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research ...

More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic, recommending that OS be ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Karen Peterson was diagnosed with stage 1 ...

In June, Orange, Calif.-based UCI Health tapped Gary Deng, MD, PhD, as director of the Integrative Oncology program at the UCI Health Chao Family Comprehensive Cancer Center, in partnership with the ...

Company Completes the Recruitment of its Commercial Leadership Team as it Remains On Track to Commence the Launch of The LIBERTY® System ...